|Other Names||BTB/POZ domain-containing protein 2, BTBD2|
|Target/Specificity||The synthetic peptide sequence is selected from aa 270-281 of HUMAN BTBD2|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Cellular Location||Cytoplasm, P-body. Note=Cytoplasmic bodies|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The C-terminus of the protein encoded by this gene binds topoisomerase I. The N-terminus contains a proline-rich region and a BTB/POZ domain (broad-complex, Tramtrack and bric a brac/Pox virus and Zinc finger), both of which are typically involved in protein-protein interactions. Subcellularly, the protein localizes to cytoplasmic bodies.
Olejnik-Schmidt, A.K., et al. Arch. Virol. 153(5):983-990(2008)
Stelzl, U., et al. Cell 122(6):957-968(2005)
Barrios-Rodiles, M., et al. Science 307(5715):1621-1625(2005)
Colland, F., et al. Genome Res. 14(7):1324-1332(2004)
Grimwood, J., et al. Nature 428(6982):529-535(2004)
Xu, L., et al. Exp. Cell Res. 288(1):84-93(2003)
Yamada, A., et al. Cancer Res. 63(11):2829-2835(2003)
Xu, L., et al. BMC Genomics 3 (1), 1 (2002) :
Carim-Todd, L., et al. Gene 262 (1-2), 275-281 (2001) :
If you have any additional inquiries please email technical services at email@example.com.